|
UBQLN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.78899999999849E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.221300E-04 |
| Normal-vs-Stage2 |
9.378300E-03 |
| Normal-vs-Stage3 |
1.361570E-04 |
| Normal-vs-Stage4 |
8.22520000000049E-05 |
| Stage1-vs-Stage2 |
6.729400E-01 |
| Stage1-vs-Stage3 |
2.695800E-01 |
| Stage1-vs-Stage4 |
1.455620E-01 |
| Stage2-vs-Stage3 |
7.441400E-01 |
| Stage2-vs-Stage4 |
4.708400E-01 |
| Stage3-vs-Stage4 |
5.575000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55759999999461E-05 |
| Normal-vs-AfricanAmerican |
2.607400E-01 |
| Normal-vs-Asian |
1.199010E-03 |
| Caucasian-vs-AfricanAmerican |
1.706390E-01 |
| Caucasian-vs-Asian |
7.828600E-01 |
| AfricanAmerican-vs-Asian |
1.653950E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.43479999999519E-05 |
| Normal-vs-Female |
2.151500E-04 |
| Male-vs-Female |
9.667600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.340200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.772030E-04 |
| Normal-vs-Age(61-80Yrs) |
7.65930000000692E-05 |
| Normal-vs-Age(81-100Yrs) |
2.533800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.829050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.669800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.363200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.597600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.867400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.041200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.464400E-01 |
| Classical-VS-Follicular |
4.062400E-03 |
| Classical-VS-Other |
9.836200E-02 |
| Classical-VS-Normal |
5.956400E-03 |
| Tall-VS-Follicular |
4.120200E-01 |
| Tall-VS-Other |
2.398800E-01 |
| Tall-VS-Normal |
3.502700E-03 |
| Follicular-VS-Other |
5.693400E-01 |
| Follicular-VS-Normal |
1.64568999999615E-05 |
| Other-VS-Normal |
3.742000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.5309399999941E-05 |
| Normal-vs-N1 |
9.6999000000042E-05 |
| N0-vs-N1 |
3.199000E-01 |
|
|
